Mary Luz
Uribe
Weizmann Institute of Science
Rejovot, IsraelPublications in collaboration with researchers from Weizmann Institute of Science (5)
2021
-
Egfr in cancer: Signaling mechanisms, drugs and acquired resistance
Cancers, Vol. 13, Núm. 11
-
Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors
Cancer Research, Vol. 81, Núm. 14, pp. 3862-3875
-
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis
Science Signaling, Vol. 14, Núm. 688
-
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
EMBO Molecular Medicine, Vol. 13, Núm. 4
2018
-
Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes
Molecular Vision, Vol. 24, pp. 43-58